Drug Type Prophylactic vaccine, Toxoid vaccine, Conjugated vaccine |
Synonyms Haemophilus influenzae type b conjugate vaccine, Haemophilus influenzae type b conjugate vaccine (Sanofi), Haemophilus type b conjugate vaccine + [9] |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (04 Feb 2000), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Haemophilus Infections | United States | 04 Feb 2000 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Meningococcal Infections | Phase 3 | Mexico | 17 Oct 2018 | |
Meningococcal Infections | Phase 3 | Russia | 17 Oct 2018 | |
Diphtheria | Phase 3 | United States | 01 Nov 2005 | |
Poliomyelitis | Phase 3 | United States | 01 Nov 2005 | |
Whooping Cough | Phase 3 | United States | 01 Nov 2005 |
Phase 3 | 525 | Rubella Virus Vaccine Live+Meningococcal Polysaccharide (Serogroups A, C, Y, and W)+Pneumococcal 13-valent Conjugate Vaccine+Rotavirus Vaccine, Live, Pentavalent (Group 1: MenACYW Conjugate Vaccine (Mexico)) | slzehjfkza = frplhhmmrr mdfnmwjzkl (swfhrzmzcd, osckairrpk - ofbjtwxfwz) View more | - | 19 Oct 2023 | ||
Rubella Virus Vaccine Live+Meningococcal Polysaccharide (Serogroups A, C, Y, and W)+Hepatitis B Vaccine+Haemophilus influenza type b Conjugate Vaccine+Pneumococcal 13-valent Conjugate Vaccine (Group 3: MenACYW Conjugate Vaccine (Russian Federation)) | xnrobknpbj = lepyveufqy vdijboxelu (cpllrbdjyj, qessrlxcqf - ghcutswbrw) View more | ||||||
Phase 3 | 2,167 | niijxovjcu = dgjjxfnaof tnaqupykob (gsvrfecmxr, guzaghrorv - twzudyqxvz) View more | - | 10 Nov 2010 | |||
niijxovjcu = cukpbnfzjl tnaqupykob (gsvrfecmxr, smuhcuycgg - ovbkvxpusa) View more |